About This Event
Zevra Therapeutics (Nasdaq: ZVRA), a commercial-stage company focused on providing therapies for people living with rare disease, visits the Nasdaq MarketSite in Times Square.
In honor of Rare Disease Month, Neil F. McFarlane, Zevra's President and Chief Executive Officer, rings the Opening Bell.